Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry

by Cecilia Smith Simonsen, Cecilia Smith Simonsen, Cecilia Smith Simonsen, Heidi Øyen Flemmen, Heidi Øyen Flemmen, Line Broch, Line Broch, Line Broch, Cathrine Brunborg, Pål Berg-Hansen, Stine Marit Moen, Elisabeth Gulowsen Celius, Elisabeth Gulowsen Celius
Published 2021-06-01

Patient‐reported outcome after treatment for definite Lyme neuroborreliosis

by Randi Eikeland, Unn Ljøstad, Geir Helgeland, Geir Sand, Heidi Øyen Flemmen, Margrete Halvorsen Bø, Ludmila Nordaa, Jone Furulund Owe, Åse Mygland, Åslaug Rudjord Lorentzen
Published 2020-04-01